A handful of large capitalization healthcare stocks have weathered the turbulent market very well this year. Overall, the healthcare sector is outperforming the broader market, providing greater potential for relative safety and superior gains. The Health Care SPDR (NYSE:XLV) ETF is up 5.14% year to date, compared to the S&P 500 SPDR (NYSE:SPY), which is still down 2.24%. Therefore, the healthcare sector has been one of the market leaders to the upside, and there are four stocks in the sector that have been performing especially well.

Abbott Labs (NYSE:ABT) is up 13.49% this year to $54.27, from $47.82. The stock has outperformed and continues to show strength. From August until now, the stock has risen steadily and created a higher low in October, while the broader market made a new low. The stock is consolidating under $55 for almost two months after hitting a 52-week high of $55.62 on October 19. A breakout above $55 is a strong signal, with a move above $55.61 confirming the uptrend is continuing. The initial upside target is $58.50 followed by $60. There is resistance at $56.50, so this area should be watched to see how the stock reacts. Primary support is at $52, and a drop below that level indicates at least short-term weakness.

Bristol-Meyers Squibb (NYSE:BMY) is having a good year so far, up 24.83% to $33.18, from $26.58. The stock has been in an uptrend all year, and recently made a new 52-week high at $33.72. The stock is pushing into overbought territory based on the RSI and may see a pullback, which should provide a buying opportunity between the 50-day moving average and $30. $30 is the primary support level, therefore a drop below is a warning signal. The current price level has not been seen since 2002, therefore there is little resistance overhead and $37 to $37.50 is the initial target.

Humana (NYSE:HUM) has been on fire, up 57.06% this year to $86.54 from $55.01. Despite being up so much already, the stock is still exhibiting strength, recently putting in a new 52-week high at $90.76. The stock been ranging over the last week between $87.50 and $85. This is a potential buying opportunity, with a stop below $85, or below $80 for longer-term traders. The November low is at $80.89 - a drop below is a warning signal. If the stock continues to make new highs, the next target is the psychologically important $100. One cause for concern is a diverging RSI indicator, it is not confirming the price moves higher. It does not mean the stock can't go higher (a divergence can last a long time) but it is something to be aware of. (For more, see An Introduction To The RSI.)

Alexion Pharmaceuticals (Nasdaq:ALXN) exploded higher in June and again in August and has not looked back since. It is up 60.11% year to date to $65.11 from $40.67. After a strong run up into October, the price has been moving sideways recently. The breakout of the range which is developing will ultimately tell if this stock still has room to the upside. A rise above $70.50 would break the range to the upside and could take the price to $80. On the other hand, there are two support levels on the downside: $62 and $59.42. If the stock breaks below $62 it is a warning signal, but a break below $59.42 is likely to bring in more aggressive selling. Like Humana, Alexion is also showing a divergence on the RSI. Price can still go higher, but it does indicate that a break to the downside is possible. (For more, see What does it mean to use technical divergence in trading?)

The Bottom Line
The healthcare sector has been doing well this year and certain stocks have provided great returns and are still showing potential. These stocks have been market leaders and are still showing price strength as the uptrends continue. That said, a break below the primary support levels mentioned are warning signals for a further correction. While there is an RSI divergence on two of the stocks, divergence is not a good timing indicator. Therefore, price is the ultimate indicator, and currently these stocks are strong until proven otherwise. (For more, see 3 Slow-And-Steady Healthcare Stocks)

Use the Investopedia Stock Simulator to trade the stocks mentioned in this stock analysis, risk free!

Charts courtesy of stockcharts.com

At the time of writing, Cory Mitchell did not own shares in any of the companies mentioned in this article.

Related Articles
  1. Professionals

    Are ETFs a Good Fit for 401(k) Plans?

    The popularity of ETFs among investors and advisors continues to grow. But are they a good fit for 401(k) plans?
  2. Mutual Funds & ETFs

    The Top Vanguard Emerging Market ETF

    Learn why growth investors should consider investing in VWO's portfolio of emerging market stocks.
  3. Investing Basics

    How to Pick the Best Muni Bonds and Muni Bond ETFs

    Municipal bonds are a good addition to a diversified portfolio as long as you choose correctly based on population and local economic trends.
  4. Chart Advisor

    Stocks at Important Technical Levels

    These stocks are breaking or holding at key support and resistance levels. How they react here impacts the direction of the price over the coming months.
  5. Mutual Funds & ETFs

    Top 3 Emerging Markets Bond Mutual Funds

    Discover detailed analysis of the top three mutual funds offering exposure to the emerging markets bonds, and learn about the suitability of these funds.
  6. Technical Indicators

    Explaining Autocorrelation

    Autocorrelation is the measure of an internal correlation with a given time series.
  7. Chart Advisor

    ChartAdvisor for October 9 2015

    Weekly technical summary of the major U.S. indexes.
  8. Investing

    The ABCs of Bond ETF Distributions

    How do bond exchange traded fund (ETF) distributions work? It’s a question I get a lot. First, let’s explain what we mean by distributions.
  9. Investing Basics

    Top Tips for Diversifying with Exotic Currencies

    Is there an opportunity in exotic currencies right now, or are you safer sticking to the major ones?
  10. Mutual Funds & ETFs

    The 3 Biggest Mutual Fund Companies in the US

    Compare and contrast the rise of America's big three institutional asset managers: BlackRock Funds, The Vanguard Group and State Street Global Advisors.
  1. What are some of the most common technical indicators that back up Doji patterns?

    The doji candlestick is important enough that Steve Nison devotes an entire chapter to it in his definitive work on candlestick ... Read Full Answer >>
  2. Can mutual funds invest in IPOs?

    Mutual funds can invest in initial public offerings (IPOS). However, most mutual funds have bylaws that prevent them from ... Read Full Answer >>
  3. Tame Panic Selling with the Exhausted Selling Model

    The exhausted selling model is a pricing strategy used to identify and trade based off of the price floor of a security. ... Read Full Answer >>
  4. Point and Figure Charting Using Count Analysis

    Count analysis is a means of interpreting point and figure charts to measure vertical price movements. Technical analysts ... Read Full Answer >>
  5. What assumptions are made when conducting a t-test?

    The common assumptions made when doing a t-test include those regarding the scale of measurement, random sampling, normality ... Read Full Answer >>
  6. Does index trading increase market vulnerability?

    The rise of index trading may increase the overall vulnerability of the stock market due to increased correlations between ... Read Full Answer >>

You May Also Like

Trading Center
You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!